MedPath

Breast Arterial Calcifications as an Imaging Biomarker of Cardiovascular Risk

Terminated
Conditions
Breast
Cardiovascular Calcification
Registration Number
NCT07156006
Lead Sponsor
IRCCS Policlinico S. Donato
Brief Summary

The goal of this observational study is to assess if there is an association between the presence of BAC and traditional cardiovascular risk factors and validate a Convolutional Neural Network (CNN) for the automatic segmentation of Breast Arterial Calcifications (BAC) in mammographic images. This study focuses on understanding the potential of BAC as an imaging biomarker for cardiovascular risk.

The main questions it aims to answer are:

* Is there an association between the presence of BAC and traditional cardiovascular risk factors?

* Can a CNN accurately segment BAC in mammographic images?

* What is the correlation between BAC and White Matter Hyperintensities (WMH) detected through brain MRI?

Participants in this study will be individuals who undergo mammographic screening. The main tasks participants will be asked to do include providing consent for participation and having mammographic images and a blood sample taken. The study will use a comparison group, comparing individuals with BAC to those without BAC, to assess potential effects on cardiovascular risk.

Detailed Description

Association between BAC and Cardiovascular Risk Factors

* Traditional cardiovascular risk factors will be analyzed, and statistical tests (t-test or U de Mann-Whitney) will be employed based on the data distribution.

* Multivariate analysis will be performed to determine the independent association between BAC load and cardiovascular risk factors.

* Linear regression will assess the relationship between BAC load and Framingham score, aiming for a clinically applicable model.

Development of CNN for BAC Segmentation

* Mammographic images will be acquired using a digital full-field mammography system as per clinical practice.

* Two experienced operators will manually segment the images to create a dataset for training, validation, and testing the CNN.

* About 60% of the images acquired in the first year will be used for training, and the remaining 40% will form the validation and test datasets.

* Performance evaluation of the CNN will be conducted using the Sørensen similarity index, Bland-Altman analysis, and Free Response Receiver Operating Characteristic (FROC).

Association between BAC and White Matter Hyperintensities (WMH)

* A subset of participants will undergo brain MRI to assess WMH.

* The association between BAC quantity in mammography and WMH load in MRI will be evaluated using machine learning techniques.

* Other small vessel disease markers, such as lacunar infarcts and microbleeds, will also be analyzed.

Patient Enrollment:

The study aims to enroll 600 women, considering a 1:1 ratio between cases and controls. With an estimated 50% adherence rate, it anticipates evaluating 1500 women over two years.

This comprehensive study integrates the development of advanced imaging techniques with clinical correlations to explore the potential of BAC as an imaging biomarker for cardiovascular risk assessment.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
149
Inclusion Criteria

Female participants. Consent to undergo mammography screening. Agreement to participate in brain MRI for a subset of the study.

Exclusion Criteria

Male participants. Age below 40. Inability or unwillingness to undergo mammography screening. Contraindications for brain MRI, including the presence of pacemaker, intracranial ferromagnetic vascular clips, intraocular metallic fragments, severe claustrophobia, inability to maintain a supine position, involuntary movements, or pregnancy.

Known history of breast cancer. Previous reductive breast surgery.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Association Between BAC and Cardiovascular Risk FactorsOne observation at the time of the mammography examination. Total time frame: 1 day.

Methodology: This aspect of the study aims to assess the association between the burden of BAC and traditional cardiovascular risk factors. Parametric and non-parametric tests will be employed to evaluate differences in BAC burden based on the presence or absence of traditional cardiovascular and gynecological risk factors.

Implications: A positive association between BAC burden and cardiovascular risk factors may emphasize the potential of BAC as a biomarker for cardiovascular risk.

Secondary Outcome Measures
NameTimeMethod
Diagnostic Performance of CNN Detection and Quantification of BAC on MammogramsOne observation at the time of the mammography examination. Total time frame: 1 day.

To assess the performance and accuracy of the Convolutional Neural Network (CNN) in automatically segmenting BAC from mammographic images. The assessment will be based on metrics such as the Sørensen similarity index, Bland-Altman analysis, and Free Response Receiver Operating Characteristic (FROC) analysis. The CNN's ability to reliably and accurately identify and delineate BAC regions in the mammograms will be the secondary focus of the outcome assessment.

Trial Locations

Locations (1)

IRCCS Policlinico San Donato

🇮🇹

San Donato Milanese, MI, Italy

IRCCS Policlinico San Donato
🇮🇹San Donato Milanese, MI, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.